583 results
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
7 May 24
Ligand Reports First Quarter 2024 Financial Results
4:03pm
companies, excess tax benefit from share-based compensation, income tax effect of adjusted reconciling items and others that are listed in the itemized … in public companies, share-based compensation expense and the effects of any discrete income tax items. Management has excluded the effects
8-K
EX-99.1
bkck xcnfq8
27 Feb 24
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
7:24am
8-K/A
3oeyk88fscoed1635rme
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
8-K/A
EX-99.1
vvfkfg
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
8-K
EX-99.1
78rqpstej
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
8-K
EX-10.1
et0bh38n683 bz5ow4
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
EX-99.1
6e52o94ux
8 Aug 23
Ligand Reports Second Quarter 2023 Financial Results
4:02pm
8-K
EX-99.1
ctkok74pf0mjbkr
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
jzh67b 7v
7 Nov 22
Ligand Reports Third Quarter 2022 Financial Results
4:04pm